Cornercap Investment Counsel Inc Enanta Pharmaceuticals Inc Transaction History

Cornercap Investment Counsel Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$11.43 - $17.02 $285 - $425	-25 Reduced 0.18%	13,760 $178,000
Q1 2024 May 10, 2024	BUY	$10.08 - $17.46 $2,509 - $4,347	249 Added 1.84%	13,785 $240,000
Q4 2023 Jan 30, 2024	SELL	$8.18 - $10.78 $3,918 - $5,163	-479 Reduced 3.42%	13,536 $127,000
Q3 2023 Nov 13, 2023	BUY	$11.09 - $22.13 $155,426 - $310,151	14,015 New	14,015 $156,000
Q4 2022 Feb 13, 2023	BUY	$40.77 - $53.73 $234,101 - $308,517	5,742 New	5,742 $267,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $177M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Cornercap Investment Counsel Inc with notifications on news.